Genetic factors predisposing to fibrosis in systemic sclerosis;Facteurs de prédisposition génétiques à la fibrose au cours de la sclérodermie systémique

Revue de Medecine Interne

Volumn 26, Issue 4, 2005, Pages 294-303

  Granel, B ^a,b   Chevillard, C ^a   Dessein, A ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL NORD   (France)

Author keywords

cytokines; Fibrosis; genes; Growth factors; Systemic sclerosis

Indexed keywords

BLEOMYCIN; CHEMOKINE; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRILLIN; FIBRONECTIN; INTERLEUKIN 1; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BLOOD VESSEL TONE; FIBROSIS; GENETIC ANALYSIS; HEREDITY; HUMAN; NONHUMAN; REVIEW; SCAR FORMATION; SYSTEMIC SCLEROSIS;

EID: 17044408029     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.12.012     Document Type: Short Survey

References (68)

1. E. Hachulla, V. Gressin, L. Guillevin, P. de Groote, J. Cabane, and P. Carpentier L'hypertension art́rielle pulmonaire assocíe ̀ la scĺrodermie syst́mique:: proposition d'un algorithme ́chocardiographique de d́pistage pour un diagnostic pŕcoce (ItinairAIR-Sĺrodermie) Rev. Med. Interne 25 2004 340 347
2. E.Y. Kissin, and J.H. Korn Fibrosis in scleroderma Rheum. Dis. Clin. North Am. 29 2003 351 369
3. H.Y. Zhang, and S.H. Phan Inhibition of myofibroblast apoptosis by transforming growth factor beta(1) Am. J. Respir. Cell Mol. Biol. 21 1999 658 665
4. K. Zhang, M. Gharaee-Kermani, B. McGarry, D. Remick, and S.H. Phan TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis J. Immunol. 158 1997 954 959
5. S. Henri, C. Chevillard, A. Mergani, P. Paris, J. Gaudart, and C. Camilla Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease J. Immunol. 169 2002 929 936
6. K. Yamane, H. Ihn, Y. Asano, M. Jinnin, and K. Tamaki Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts J. Immunol. 171 2003 3855 3862
7. C. Chizzolini, Y. Parel, C. De Luca, A. Tyndall, A. Akesson, and A. Scheja Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha Arthritis Rheum. 48 2003 2593 2604
8. T. Tsuruda, L.C. Costello-Boerrigter, and J.C. Burnett Jr. Matrix metalloproteinases: pathways of induction by bioactive molecules Heart Fail. Rev. 9 2004 53 61
9. A. Gabrielli, C. Di Loreto, R. Taborro, M. Candela, P. Sambo, and C. Nitti Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon Clin. Immunol. Immunopathol. 68 1993 340 349
10. T. Kawakami, H. Ihn, W. Xu, E. Smith, C. LeRoy, and M. Trojanowska Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype J. Invest. Dermatol. 110 1998 47 51
11. H. Ihn, K. Yamane, M. Kubo, and K. Tamaki Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors Arthritis Rheum. 44 2001 474 480
12. A. Ludwicka, T. Ohba, M. Trojanowska, A. Yamakage, C. Strange, and E.A. Smith Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma J. Rheumatol. 22 1995 1876 1883
13. J. Varga Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis Arthritis Rheum. 46 2002 1703 1713
14. T. McGaha, S. Saito, R.G. Phelps, R. Gordon, N. Noben-Trauth, and W.E. Paul Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes J. Invest. Dermatol. 116 2001 136 143
15. L.L. McCormick, Y. Zhang, E. Tootell, and A.C. Gilliam Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma J. Immunol. 163 1999 5693 5699
16. T. Yamamoto, S. Takagawa, I. Katayama, and K. Nishioka Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma Clin. Immunol. 92 1999 6 13
17. H. Higley, K. Persichitte, S. Chu, W. Waegell, R. Vancheeswaran, and C. Black Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon Arthritis Rheum. 37 1994 278 288
18. Y. Mori, S.J. Chen, and J. Varga Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts Arthritis Rheum. 48 2003 1964 1978
19. C. Dong, S. Zhu, T. Wang, W. Yoon, Z. Li, and R.J. Alvarez Deficient Smad7 expression: a putative molecular defect in scleroderma Proc. Natl. Acad. Sci. USA 99 2002 3908 3913
20. K. Takehara Hypothesis: pathogenesis of systemic sclerosis J. Rheumatol. 30 2003 755 759
21. X. Shi-wen, D. Pennington, A. Holmes, A. Leask, D. Bradham, and J.R. Beauchamp Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis Exp. Cell Res. 259 2000 213 224
22. A. Igarashi, K. Nashiro, K. Kikuchi, S. Sato, H. Ihn, and M. Fujimoto Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders J. Invest. Dermatol. 106 1996 729 733
23. S. Sato, T. Nagaoka, M. Hasegawa, T. Tamatani, T. Nakanishi, and M. Takigawa Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis J. Rheumatol. 27 2000 149 154
24. J.S. Perlish, R.I. Bashey, R.E. Stephens, and R. Fleischmajer Connective tissue synthesis by cultured scleroderma fibroblasts. I. In vitro collagen synthesis by normal and scleroderma dermal fibroblasts Arthritis Rheum. 19 1976 891 901
25. A. Holmes, D.J. Abraham, Y. Chen, C. Denton, X. Shi-wen, and C.M. Black Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1 J. Biol. Chem. 278 2003 41728 41733
26. T. Mori, S. Kawara, M. Shinozaki, N. Hayashi, T. Kakinuma, and A. Igarashi Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model J. Cell. Physiol. 181 1999 153 159
27. M.R. Duncan, K.S. Frazier, S. Abramson, S. Williams, H. Klapper, and X. Huang Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP FASEB J. 13 1999 1774 1786
28. R. Stratton, X. Shiwen, G. Martini, A. Holmes, A. Leask, and T. Haberberger Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients J. Clin. Invest. 108 2001 241 250
29. M.C. Tamby, Y. Chanseaud, L. Guillevin, and L. Mouthon New insights into the pathogenesis of systemic sclerosis Autoimmun. Rev. 2 2003 152 157
30. T.L. McGaha, and C.A. Bona Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma Autoimmun. Rev. 1 2002 174 181
31. M. Galindo, B. Santiago, M. Rivero, J. Rullas, J. Alcami, and J.L. Pablos Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression Arthritis Rheum. 44 2001 1382 1386
32. T.L. McGaha, M. Le, T. Kodera, C. Stoica, J. Zhu, and W.E. Paul Molecular mechanisms of interleukin-4-induced up-regulation of type I collagen gene expression in murine fibroblasts Arthritis Rheum. 48 2003 2275 2284
33. C.G. Lee, R.J. Homer, Z. Zhu, S. Lanone, X. Wang, and V. Koteliansky Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1) J. Exp. Med. 194 2001 809 821
34. Z. Zhu, B. Ma, T. Zheng, R.J. Homer, C.G. Lee, and I.F. Charo IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling J. Immunol. 168 2002 2953 2962
35. J.A. Elias, T. Zheng, C.G. Lee, R.J. Homer, Q. Chen, and B. Ma Transgenic modeling of interleukin-13 in the lung Chest 123 2003 339S 345S
36. T. Yamamoto, I. Katayama, and K. Nishioka Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis J. Rheumatol. 25 1998 314 317
37. K. Takagi, Y. Kawaguchi, M. Hara, T. Sugiura, M. Harigai, and N. Kamatani Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features Clin. Exp. Immunol. 134 2003 538 544
38. Y. Allanore, D. Borderie, P. Hilliquin, A. Hernvann, M. Levacher, and H. Lemarechal Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells Rheumatology (Oxford) 40 2001 1089 1096
39. M. Matucci Cerinic, and M.B. Kahaleh Beauty and the beast. The nitric oxide paradox in systemic sclerosis Rheumatology (Oxford) 41 2002 843 847
40. M. Le Hir, M. Martin, and C. Haas A syndrome resembling human systemic sclerosis (scleroderma) in MRL/lpr mice lacking interferon-gamma (IFN-gamma) receptor (MRL/lprgammaR-/-) Clin. Exp. Immunol. 115 1999 281 287
41. Y. Zhang, L.L. McCormick, S.R. Desai, C. Wu, and A.C. Gilliam Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation J. Immunol. 168 2002 3088 3098
42. R.W. Johnson, M.B. Tew, and F.C. Arnett The genetics of systemic sclerosis Curr. Rheumatol. Rep. 4 2002 99 107
43. F.C. Arnett, M. Cho, S. Chatterjee, M.B. Aguilar, J.D. Reveille, and M.D. Mayes Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts Arthritis Rheum. 44 2001 1359 1362
44. A.R. McGregor, A. Watson, E. Yunis, J.P. Pandey, K. Takehara, and J.T. Tidwell Familial clustering of scleroderma spectrum disease Am. J. Med. 84 1988 1023 1032
45. V.D. Steen, D.L. Powell, and T.A. Medsger Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis Arthritis Rheum. 31 1988 196 203
46. N.C. Lambert, O. Distler, U. Muller-Ladner, T.S. Tylee, D.E. Furst, and J.L. Nelson HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian men Arthritis Rheum. 43 2000 2005 2010
47. R. Hata, J. Akai, A. Kimura, O. Ishikawa, M. Kuwana, and H. Shinkai Association of functional microsatellites in the human type I collagen alpha2 chain (COL1A2) gene with systemic sclerosis Biochem. Biophys. Res. Commun. 272 2000 36 40
48. J. Akai, A. Kimura, and R.I. Hata Transcriptional regulation of the human type I collagen alpha2 (COL1A2) gene by the combination of two dinucleotide repeats Gene 239 1999 65 73
49. E. Susol, A.L. Rands, A. Herrick, N. McHugh, J.H. Barrett, and W.E. Ollier Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis Rheumatology (Oxford) 39 2000 1332 1336
50. A. Crilly, J. Hamilton, C.J. Clark, A. Jardine, and R. Madhok Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis Ann. Rheum. Dis. 61 2002 678 681
51. Y. Sugiura, S. Banno, Y. Matsumoto, T. Niimi, T. Yoshinouchi, and Y. Hayami Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis J. Rheumatol. 30 2003 1520 1523
52. F.K. Tan, F.C. Arnett, J.D. Reveille, C. Ahn, S. Antohi, and T. Sasaki Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles Arthritis Rheum. 43 2000 2464 2471
53. F.C. Arnett, F.K. Tan, Y. Uziel, R.M. Laxer, B.R. Krafchik, and S. Antohi Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma Arthritis Rheum. 42 1999 2656 2659
54. F.K. Tan, D.N. Stivers, M.W. Foster, R. Chakraborty, R.F. Howard, and D.M. Milewicz Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population Arthritis Rheum. 41 1998 1729 1737
55. F.K. Tan, N. Wang, M. Kuwana, R. Chakraborty, C.A. Bona, and D.M. Milewicz Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations Arthritis Rheum. 44 2001 893 901
56. D.D. Wallis, F.K. Tan, C.M. Kielty, M.D. Kimball, F.C. Arnett, and D.M. Milewicz Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma) Arthritis Rheum. 44 2001 1855 1864
57. D.D. Wallis, F.K. Tan, R. Kessler, M.D. Kimball, J.S. Cretoiu, and F.C. Arnett Fibrillin 1 abnormalities in dermal fibroblast cultures from first-degree relatives of patients with systemic sclerosis (scleroderma) Arthritis Rheum. 50 2004 329 332 51
58. P. Birembaut, P. Cahuzac, H. Delhomme, Y. Caron, J. Labat-Robert, and L. Robert Distribution of fibronectin in the skin of patients with scleroderma Ann. Dermatol. Venereol. 109 1982 933 937
59. J.J. Avila, P.A. Lympany, P. Pantelidis, K.I. Welsh, C.M. Black, and R.M. Du Bois Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis Am J Respir Cell Mol Biol 20 1999 106 112 52
60. V. Young, M. Ho, H. Vosper, J.J. Belch, and C.N. Palmer Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis Rheumatology (Oxford) 41 2002 869 875
61. F. Takeuchi, H. Nabeta, M. Fussel, K. Conrad, and K.H. Frank Association of the TNFa13 microsatellite with systemic sclerosis in Japanese patients Ann. Rheum. Dis. 59 2000 293 296
62. J.P. Pandey, and F. Takeuchi TNF-alpha and TNF-beta gene polymorphisms in systemic sclerosis Hum. Immunol. 60 1999 1128 1130
63. H. Sato, A.L. Lagan, C. Alexopoulou, D.A. Vassilakis, T. Ahmad, and P. Pantelidis The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma Arthritis Rheum. 50 2004 558 564
64. C. Fatini, F. Gensini, E. Sticchi, B. Battaglini, C. Angotti, and M.L. Conforti High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis Am. J. Med. 112 2002 540 544
65. M.B. Bolster, A. Ludwicka, S.E. Sutherland, C. Strange, and R.M. Silver Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis Arthritis Rheum. 40 1997 743 751
66. E. Renzoni, P. Lympany, P. Sestini, P. Pantelidis, A. Wells, and C. Black Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis Arthritis Rheum. 43 2000 1633 1640
67. Y. Kawaguchi IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis Clin. Exp. Immunol. 97 1994 445 450
68. B. Hutyrova, J. Lukac, V. Bosak, M. Buc, R. Du Bois, and M. Petrek Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis J. Rheumatol. 31 2004 81 84